Who Paid My Doc
Bizengri
Drug Hematology/Oncology
NDC 71837-1000-2
General payments
$458,202
Research payments
$1,177,302
Through program year 2025, $458,202 in general payments and $1,177,302 in research payments were reported against Bizengri (Hematology/Oncology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $458,202 | 326 |
| 2025 | Research | $1,177,302 | 104 |
Breakdown
The top 5 of 61 recipients; each share is of general payments naming this product in 2025.
The top 5 of 13 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 22 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
326 general · 104 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.